Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2026-06-08 @ 2:12 AM
Study NCT ID:
NCT01275066
Status:
COMPLETED
Last Update Posted:
2014-07-07
First Post:
2011-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Sponsor:
BioMarin Pharmaceutical
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | MPS IV A | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Mucopolysaccharidosis IV type A | View |
| None | MPS IV Type A | View |
| None | Mucopolysaccharidosis IVA | View |
| None | MPS IVA | View |
| None | Morquio A Syndrome | View |
| None | Lysosomal Storage Disorder | View |
| None | LSD | View |
| None | N-acetylgalactosamine-6-sulfatase | View |
| None | N-acetylgalactosamine-6-sulfate sulfatase | View |
| None | galactose-6-sulfatase | View |
| None | GALNS | View |
| None | enzyme replacement therapy | View |
| None | ERT | View |